The activation of PKCα has been reported to be implicated in the etiology of diabetes or obesity in animal models [51, 52], and SRPO has been reported to inhibit the 5-HT2AR/G protein/PKC pathway in monocytes [10]. Here, PRRT2 is linked to obesity due to melanocortin 4 receptor deficiency.